The NF1 gene, altered in approximately 20% of GBs, is a regulator of Ras activity in the RAS/MAPK signalling pathway associated with the development of tumours of the central nervous system and a short OS and prognosis (37). The gene discussed is NF1; the disease is Guillain-Barre syndrome.